supported the National Natural Science Foundation of China,No. 81970760 (to YT);the Natural Science Foundation of Liaoning Province,No. 2021-MS-201 (to YX);the 345 Talent Project of Shengjing Hospital of China Medical University,No. M0370 (to YT);the 345 Talent Project of Shengjing Hospital of China Medical University,No. M0395 (to YX)。
Cerebral ischemia is a serious disease that triggers sequential pathological mechanisms, leading to significant morbidity and mortality. Although most studies to date have typically focused on the lysosome, a single o...
The Natural Science Foundation of China (Nos.21732008,and 81771205);CAMS Innovation Fund for Medical Sciences (CIFMS,Nos.CIFMS-2022-I2M-JB-009,China);The National Postdoctoral Program for Innovative Talents (No.BX20180053,China)
Neuropathic pain is a chronic disease that severely afflicts the life and emotional status of patients,but currently available treatments are often ineffective.Novel therapeutic targets for the alleviation of neuropat...
Stellate ganglion blockade (SGB) protects patients from focal cerebral ischemic injury, and transection of the cervical sympathetic trunk (TCST) in a rat model can mimic SGB in humans. The purpose of this study wa...